Genmab — Februar 2021
-
Anthony nævner readiness to launch for epco i 2021
-
Nope - dkk. Primært usd development på kasse/obligationsbeholdning
-
Guidance på dara har intet med holdning til arbitrage at gøre - det er rent forsigtighed regnskabsmæssigt
-
Jep
-
Og modregnet gevinst på curevac
-
Fight our rights
-
Abbvie bidrager med dkk500m i omkostningsrefusion i 2021
-
Ved det ikke - men den effektive skattesats er 19,4%
-
Det var præsentationen - nu Q&A
-
Citis vurdering (Verdult) siger at JJ tilbageholder svarende til dkk 450m danske kroner
-
Lyder noget voldsomt
-
Sorry - det var Anthony der siger at dkk 900m kr. skal deles lige mellem lavere usd og JJ tilbageholdelse
-
ca. 2 % af ca 18 % ?
-
Du tænker 2 procent point - ikke sandt?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind